(byoo-SUL-fan)
This page contains brief information about busulfan and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Myleran
FDA label information for this drug is available at DailyMed.
Use in Cancer
Busulfan is approved to treat:
- Chronic myelogenous leukemia (CML).
- It is used as palliative treatment. This use is approved for the Myleran brand of busulfan.
- It is also used with other drugs to prepare patients with CML for a stem cell transplant. This use is approved for the Busulfex brand of busulfan.
Busulfan is also being studied in the treatment of other types of cancer.
More About Busulfan
Definition from the NCI Drug Dictionary – Detailed scientific definition and other names for this drug.
More About Busulfan (Myleran) and Busulfan (Bulsulfex) – Lay language summaries of important information about these drugs. MedlinePlus information may include the following:
- warnings about the drug,
- what the drug is used for and how it is used,
- what you should tell your doctor before using the drug,
- what you should know about the drug before using it,
- other drugs that may interact with the drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Clinical Trials Accepting Patients
Find Clinical Trials for Busulfan – Check for trials from NCI’s list of cancer clinical trials now accepting patients.
